Methodology, efficacy and safety of fecal microbiota transplant in treating inflammatory bowel disease
Fecha
2020Autor
Ding, Xiao
Yang, Xiaozhong
Wang, Honggang
Resumen
Fecal microbiota transplantation (FMT), as an emerging therapy, can be used to treat microbiota related diseases.
Progresses in donor screening, washed microbiota preparation, microbiota delivery routes, clinical administrative
strategies, and long-term safety are moving FMT forward. Increasing clinical studies, especially those randomized
controlled trials about ulcerative colitis and pilot real-word studies about serious inflammatory bowel disease
(IBD), have been conducted. This review presents the latest findings about the efficacy, safety and methodology of
FMT in treating IBD.
Palabras clave
Washed microbiota transplantation; Transendoscopic enteral tubing; Ulcerative colitis; Crohn's disease; Adverse event; SafetyEnlace al recurso
https://doi.org/10.1016/j.medmic.2020.100028Colecciones
Estadísticas Google Analytics
Comentarios
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.